Harnessing Imaging Tools to Guide Immunotherapy Trials Policy Review

This document focuses on new ways to treat cancer using immunotherapy.


Harnessing Imaging Tools to Guide Immunotherapy Trials Policy Review - cover page
Document type
Other
Language
English
Pages
11
File format
PDF
File size
284 KB
Published
24 November, 2023
Updated
24 November, 2023
MD5 checksum
9165C923B2BE732F9635C6552D979C83

About this manual

This Policy Review in The Lancet Oncology summarizes a National Cancer Institute Clinical Imaging Steering Committee workshop held on April 6, 2021, entitled Harnessing Imaging Tools to Guide Immunotherapy Trials. It brings together imaging experts and oncologists to review diagnostic imaging tools and response-assessment guidelines for phase 2 and 3 immunotherapy clinical trials.

The review covers standard-of-care imaging such as CT, magnetic resonance, and FDG-PET, along with criteria including RECIST, iRECIST, and iRANO. It also examines investigational approaches such as radiomics, functional MRI agents, and novel molecular-imaging PET agents, and outlines paths for validating these tools through prospective trials or retrospective data analysis.

What's inside

  • Background
  • Current clinical landscape and standard of care
  • The global landscape of immunotherapy oncology trials and NCI strategy
  • Current Status
  • Evolving size-based metrics
  • Advanced imaging techniques
  • Molecular imaging agents

Frequently asked questions

What was the purpose of the National Cancer Institute Clinical Imaging Steering Committee meeting?

The meeting was convened to document current challenges and opportunities and identify next steps in immunotherapy diagnostic imaging.

When was the virtual meeting on harnessing imaging tools held?

The virtual meeting entitled Harnessing Imaging Tools to Guide Immunotherapy Trials was held on April 6, 2021.

Which standard-of-care diagnostic imaging tools are reviewed?

The review covers the utility of CT, magnetic resonance, and F-fluorodeoxyglucose (FDG)-PET for assessing immunotherapy.

Download PDF (284 KB)

Also Manuals